Healthy subjects G20 G63.2
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Male and female patiens with diabetic neuropathy ages 18-75 years will be inculded following full written informed consent. Furthermore male and female healthy control subjects as wella as male and female patiens with Parkinson's disease ages 18-75 years will be inculded following full written informed consent. Each diagnosis (Parkinsion's disease or diabetic neuropathy) has to be cproven previously.
Exclusion criteria
Exclusion criteria: Patient arms: - intake of beta-blockers within 14 days previous to beginning of the study - intake of antidepressants within 3 months previous to beginning of the study - dermatologic comorbidities affecting the testing sites - known allergy to phenylephrine - consumption of more than 10 cigarettes per day - consumption of one alcoholic beverage per day - consumption of any nicotine, caffeine or alcohol at the testing day Control arm: -any acute of chronic disease -chronic intake of medication - consumption of more than 10 cigarettes per day - consumption of one alcoholic beverage per day - consumption of any nicotine, caffeine or alcohol at the testing day
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of hair follicle silicone indentations - analysis through counting of the indentation in silicon scans- analysis on the day of measurement | — |
Secondary
| Measure | Time frame |
|---|---|
| Volume and area spread of hair follicle silicone indentations - analysis through digital image analysis of the indentations in silicon scans- analysis on the day of measurement | — |
Countries
Germany
Contacts
Klinik und Poliklinik für Neurologie Universitätsklinikum Carl Gustav Carus